top of page
Varuna_LOGO.jpg

The VARUNA on-line self assessment platform has the objectives to:

  • quantify GCP compliance in HIV care across Europe,

  • identify RT tools routinely used in clinical practice across Europe,

  • analyse it by geography as well as to

  • use self-assessment as a strategy for promotion of GCP compliance 

What do you have to do?

1. The self-assessment will take less than 10 minutes. It will be anonymous.
(You can save your progress and complete it over a period of time)


2. On completion, you’ll receive a GCP score and a certificate of participation. (You can re-do the self-assessment following a review of your routine clinical practice and track your improvement.)

90-90-90 and saving lifes

The self-assessment will not only support your personal professional development but will also help characterise current clinical practice and provide insights into how to improve drug resistance management expertise.

 

There’s one goal: reach the 90-90-90 targets and save lives.

The VARUNA GCP survey has been finalised.

See the questionnaire with explanations and continue your learning process

VARUNA has been realised by the EuResist Network in collaboration with McCann Healthcare

Project supported by a grant from Gilead Sciences Europe Ltd.

PROJECTS

EuResist Network GEIE
Via Guido Guinizelli, 98/100 - 00152 Rome - Italy
Tel. +39 065882352 

VAT N. 09950311002 / reg. N° RM-1199300

email: info@euresist.org

Follow us on ​LinkedIn


 

CEO: Dr. Francesca Incardona

e-mail: f.incardona@euresist.org

EuResist Network GEIE | © 2017-2022 All Right Reserved

The EuResist Network is open to new partners of proved or potential scientific value for expanding both database and scientific programme. Co-operation with developing countries with high rates of HIV infections is mostly welcome.

All the partners have one representative in the EuResist Network Scientific Board. The Board evaluates requests to access the EIDB for scientific studies. Partner's activities and data are protected by the data and authorship policy.

bottom of page